Celemics Decides to Issue 1.38 Million New Shares via Third-Party Allotment, Raising Concerns Over Dilution and Undefined Use of Funds
Celemics decided on March 31, 2026 to issue 1,384,578 new shares via third-party allotment at an issue price of 8,378 KRW, a 10.0% discount to the reference price.
The proceeds of approximately 11.6 billion KRW are intended for the acquisition of securities of other corporations, but the specific target has not been determined, raising concerns about transparency and efficient use of capital.
The new shares represent about 14.1% of the total outstanding shares, leading to significant dilution of existing shareholders' equity. However, all new shares will be deposited with Korea Securities Depository for a one-year lock-up, limiting short-term selling pressure.
Allottees include Suphigen New Technology Investment Association No. 1, individual investors, and some unregistered officers, selected for rapid fundraising rather than strategic partnership, which is not a positive governance signal.
[AI Summary]Celemics' rights offering involves massive dilution of 14% with unclear use of proceeds and low counterparty credibility, posing significant risk to shareholder value. Although the lock-up mitigates immediate selling pressure, the medium to long-term stock outlook remains negative.
KOSDAQ Filing Information
[Correction of Description] Report on Major Events (Decision on Paid-in Capital Increase)